{"anticipatedPostingDate":"2026-09","denomUnitsSelected":"Participants","description":"DOR: Time from first documentation of objective response subsequently confirmed, until first documentation of confirmed PD or death due to any cause, whichever occurred first. PD= increase of \\>=25% from lowest value in \\>=1 of following (serum M-protein \\[absolute increase \\>=0.5g/dL\\]; serum M-protein increase \\>=1g/dL \\[when lowest M-protein \\>=5g/dL\\]; urine M-protein \\[absolute increase \\>=200mg/24h\\]; participants without measurable serum \\& urine M-protein levels, difference between involved \\& uninvolved sFLC levels \\[absolute increase \\>10mg/dL\\]; in participants without measurable serum, urine M-protein levels \\& involved sFLC levels: bone marrow plasma-cell % irrespective of baseline status \\[absolute increase \\>=10%\\]; appearance of new lesion,\\>=50% increase from nadir in SPD of \\>1 lesion, or \\>=50% increase in longest diameter of previous lesion \\>1cm in short axis; \\>=50% increase in circulating plasma cells \\[\\>=200cells/μL\\] if this is the only measure of disease.","reportingStatus":"NOT_POSTED","timeFrame":"From first documentation of objective response subsequently confirmed until confirmed PD or death due to any cause, or start of new anticancer therapy, whichever occurred first, or censoring (up to approximately 37 months)","title":"Duration of Response (DOR) as Per IMWG Criteria by Investigator Assessment","type":"SECONDARY"}